Publications 2012

1.  Asad S, Nikamo P, Gyllenberg A, Bennet H, Hansson O, Wierup N, Carlsson A, Forsander G, Ivarsson SA, Larsson H, Lernmark A, Lindblad B, Ludvigsson J, Marcus C, Rønningen KS, Nerup J, Pociot F, Luthman H, Fex M, Kockum I (2012) HTR1A a novel type 1 diabetes susceptibility gene on chromosome 5p13-q13. PLoS ONE 7: e35439.

2.  Bak J, Brandt-Christensen M, Sestoft DM, Zoffmann V (2012) Mechanical Restraint-Which Interventions Prevent Episodes of Mechanical Restraint?-A Systematic Review. Perspectives in Psychiatric Care 48: 83-94.

3.  Banasik K, Hollensted M, Andersson E, Sparsø T, Sandbæk A, Lauritzen T, Jørgensen T, Witte DR, Pedersen O, Hansen T (2012) The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals. BMC Medical Genetics 13.

4.  Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J (2012) The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: A randomised controlled trial. Diabetologia 55: 3155-3162.

5.  Brøns C, Jacobsen S, Hiscock N, White A, Nilsson E, Dunger D, Astrup A, Quistorff B, Vaag A (2012) Effects of high-fat overfeeding on mitochondrial function, glucose and fat metabolism, and adipokine levels in low-birth-weight subjects. American Journal of Physiology - Endocrinology and Metabolism 302: E43-E51.

6.  Burgdorf KS, Gjesing AP, Grarup N, Justesen JM, Sandholt CH, Witte DR, Jørgensen T, Madsbad S, Hansen T, Pedersen O (2012) Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individuals. Diabetologia 55: 105-113.

7.  Byberg S, Soborg B, Andersson M, Bjerregaard P, Jørgensen ME (2012) Diabetes is a risk factor for tuberculosis in the Inuit population of Greenland. European Respiratory Journal 40: 1289-1291.

8.  Byberg S, Hansen ALS, Christensen DL, Vistisen D, Aadahl M, Linneberg A, Witte DR (2012) Sleep duration and sleep quality are associated differently with alterations of glucose homeostasis. Diabetic Medicine 29: e354-e360.

9.  Cameron AJ, Magliano DJ, Shaw JE, Zimmet PZ, Carstensen B, Alberti KG, Tuomilehto J, Barr EL, Pauvaday VK, Kowlessur S, Soderberg S (2012) The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol 41: 484-494.

10.  Carstensen B, Witte DR, Friis S (2012) Cancer occurrence in Danish diabetic patients: Duration and insulin effects. Diabetologia 55: 948-958.

11.  Carstensen B, Witte DR, Friis S (2012) Erratum: Cancer occurrence in Danish diabetic patients: Duration and insulin effects (Diabetologia DOI: 10.1007/s00125-011-2381-4). Diabetologia 55: 1223.

12.  Carstensen B (2012) Request for clarification from Ruiter et al regarding 'Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: Results from a large population-based follow-up study'. Diabetologia 55: 857-858.

13.  Cherry G, Frisch A, Hillen MA, Martinelli V, Pype PF, Scholl I, Gudzune KA (2012) Advice for junior researchers – Lessons learned from the 2011 Y-EACH Junior Investigators' Workshop. Patient Educ Couns 89: 214-215.

14.  Christensen DL, Faurholt-Jepsen D, Boit MK, Mwaniki DL, Kilonzo B, Tetens I, Kiplamai FK, Cheruiyot SC, Friis H, Borch-Johnsen K, Wareham NJ, Brage S (2012) Cardiorespiratory fitness and physical activity in Luo, Kamba, and Maasai of rural Kenya. American Journal of Human Biology 24: 723-729.

15.  Christensen DL, Alcalá-Sánchez I, Leal-Berumen I, Conchas-Ramirez M, Brage S (2012) Physical activity, cardio-respiratory fitness, and metabolic traits in rural Mexican Tarahumara. American Journal of Human Biology 24: 558-561.

16.  Christensen TM, Gade-Rasmussen B, Pedersen LW, Hommel E, Holstein PE, Svendsen OL (2012) Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker. Journal of Diabetes and its Complications 26: 430-434.

17.  Cooper JD, Howson JMM, Smyth D, Walker NM, Stevens H, Yang JHM, She JX, Eisenbarth GS, Rewers M, Todd JA, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Pociot F, Rich SS (2012) Confirmation of novel type 1 diabetes risk loci in families. Diabetologia 55: 996-1000.

18.  Due-Christensen M, Zoffmann V, Hommel E, Lau M (2012) Can sharing experiences in groups reduce the burden of living with diabetes, regardless of glycaemic control? Diabetic Medicine 29: 251-256.

19.  Fagerholm E, Ahlqvist E, Forsblom C, Sandholm N, Syreeni A, Parkkonen M, McKnight AJ, Tarnow L, Maxwell AP, Parving HH, Groop L, Groop PH (2012) SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes. Diabetologia 55: 2386-2393.

20.  Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Witte DR, Andersen AB, Friis H (2012) The role of anthropometric and other predictors for diabetes among urban Tanzanians with tuberculosis. International Journal of Tuberculosis and Lung Disease 16: 1680-1685.

21.  Faurholt-Jepsen D, Range N, PrayGod G, Kidola J, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Martinussen T, Krarup H, Witte DR, Andersen TB, Friis H (2012) The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania. BMC Infectious Diseases 12.

22.  Faurholt-Jepsen D, Range N, PrayGod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Krarup H, Witte DR, Andersen AB, Friis H (2012) The role of diabetes on the clinical manifestations of pulmonary tuberculosis. Tropical Medicine and International Health 17: 877-883.

23.  Fox CS, Matsushita K, Woodward M, Bilo HJG, Chalmers J, Lambers Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, De Jong PE, Wen CP, Nelson RG (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis. The Lancet 380: 1662-1673.

24.  Friedrichsen M, Ribel-Madsen R, Mortensen B, Hansen CN, Alibegovic AC, Højbjerre L, Sonne MP, Wojtaszewski JFP, Stallknecht B, Dela F, Vaag A (2012) Muscle inflammatory signaling in response to 9 days of physical inactivity in young men with low compared with normal birth weight. European Journal of Endocrinology 167: 829-838.

25.  Færch K, Hjølund K, Vind BF, Vaag A, Dalgård C, Nielsen F, Grandjean P (2012) Increased serum concentrations of persistent organic pollutants among prediabetic individuals: Potential role of altered substrate oxidation patterns. Journal of Clinical Endocrinology and Metabolism 97: E1705-E1713.

26.  Færch K, Bergman B, Perreault L (2012) Does insulin resistance drive the association between hyperglycemia and cardiovascular risk? PLoS ONE 7: e39260.

27.  Gjesing AP, Pedersen O (2012) 'Omics'-driven discoveries in prevention and treatment of type 2 diabetes. European Journal of Clinical Investigation 42: 579-588.

28.  Gruden G, Loiacono M, Barutta F, Tricarico M, Chaturvedi N, Mengozzi G, Schalkwijk C, Witte DR, Stehouwer CD, Fuller JH, Pinach S, Perin PC, Manzo M, Bruno G (2012) NH 2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB prospective complications study: The role of tumor necrosis factor-. Diabetes Care 35: 1931-1936.

29.  Gruden G, Barutta F, Chaturvedi N, Schalkwijk C, Stehouwer CD, Witte DR, Fuller JH, Perin PC, Bruno G (2012) Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: The EURODIAB prospective complications study. Diabetes Care 35: 1598-1604.

30.  Gruden G, Giunti S, Barutta F, Chaturvedi N, Witte DR, Tricarico M, Fuller JH, Perin PC, Bruno G (2012) QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. Diabetes Care 35: 125-127.

31.  Handlos LN, Witte DR, Mwaniki DL, Boit MK, Kilonzo B, Friis H, Hansen AW, Borch-Johnsen K, Tetens I, Christensen DL (2012) Abdominal obesity has the highest impact on metabolic profile in an overweight African population. Annals of Human Biology 39: 530-533.

32.  Hansen ALS, Wijndaele K, Owen N, Magliano DJ, Thorp AA, Shaw JE, Dunstan DW (2012) Adverse associations of increases in television viewing time with 5-year changes in glucose homoeostasis markers: The AusDiab study. Diabetic Medicine 29: 918-925.

33.  Hansen MB, Jensen ML, Carstensen B (2012) Causes of death among diabetic patients in Denmark. Diabetologia 55: 294-302.

34.  Helgadottir A, Gretarsdottir S, Thorleifsson G, Holm H, Patel RS, Gudnason T, Jones GT, Van Rij AM, Eapen DJ, Baas AF, Tregouet DA, Morange PE, Emmerich J, Lindblad B, Gottster A, Kiemeny LA, Lindholt JS, Sakalihasan N, Ferrell RE, Carey DJ, Elmore JR, Tsao PS, Grarup N, Jørgensen T, Witte DR, Hansen T, Pedersen O, Pola R, Gaetani E, Magnadottir HB, Wijmenga C, Tromp G, Ronkainen A, Ruigrok YM, Blankensteijn JD, Mueller T, Wells PS, Corral J, Soria JM, Souto JC, Peden JF, Jalilzadeh S, Mayosi BM, Keavney B, Strawbridge RJ, Sabater-Lleal M, Gertow K, Baldassarre D, Nyyssnen K, Rauramaa R, Smit AJ, Mannarino E, Giral P, Tremoli E, De Faire U, Humphries SE, Hamsten A, Haraldsdottir V, Olafsson I, Magnusson MK, Samani NJ, Levey AI, Markus HS, Kostulas K, Dichgans M, Berger K, Kuhlenbumer G, Ringelstein EB, Stoll M, Seedorf U, Rothwell PM, Powell JT, Kuivaniemi H, Onundarson PT, Valdimarsson E, Matthiasson SE, Gudbjartsson DF, Thorgeirsson G, Quyyumi AA, Watkins H, Farrall M, Thorsteinsdottir U, Stefansson K (2012) Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. Journal of the American College of Cardiology 60: 722-729.

35.  Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J (2012) Authors' reply to Yudkin and Lipska. BMJ (Online) 344.

36.  Hempler NF, Krasnik A, Pisinger C, Jorgensen T (2012) The relationship between changes in health behaviour and initiation of lipid-lowering and antihypertensive medications in individuals at high risk of ischaemic heart disease. BMC Public Health 12: 626.

37.  Heraclides AM, Chandola T, Witte DR, Brunner EJ (2012) Work stress, obesity and the risk of type 2 diabetes: Gender-specific bidirectional effect in the whitehall II study. Obesity 20: 428-433.

38.  Hida K, Poulsen P, Teshigawara S, Nilsson E, Friedrichsen M, Ribel-Madsen R, Grunnet L, Lund SS, Wada J, Vaag A (2012) Impact of circulating vaspin levels on metabolic variables in elderly twins. Diabetologia 55: 530-532.

39.  Hjorth MF, Kloster S, Girma T, Faurholt-Jepsen D, Andersen G, Kaestel P, Brage S, Friis H (2012) Level and intensity of objectively assessed physical activity among pregnant women from urban Ethiopia. BMC Pregnancy Childbirth 12: 154.

40.  Howson JMM, Cooper JD, Smyth DJ, Walker NM, Stevens H, She JX, Eisenbarth GS, Rewers M, Todd JA, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Pociot F, Rich SS (2012) Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes. Diabetes 61: 3012-3017.

41.  Husemoen LLN, Thuesen BH, Fenger M, Jørgensen T, Glümer C, vensson J, vesen L, itte DR, inneberg A (2012) Serum 25(OH)D and type 2 diabetes association in a general population: A prospective study. Diabetes Care 35: 1695-1700.

42.  Jacobsen SC, Brøns C, Bork-Jensen J, Ribel-Madsen R, Yang B, Lara E, Hall E, Calvanese V, Nilsson E, Jørgensen SW, Mandrup S, Ling C, Fernandez AF, Fraga MF, Poulsen P, Vaag A (2012) Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men. Diabetologia 55: 3341-3349.

43.  Jensen TM, Witte DR, Pieragostino D, McGuire JN, Schjerning ED et al. (2012) Association between protein signals and type 2 diabetes incidence. Acta Diabetologica. In press.

44.  Jeppesen C, Jorgensen ME, Bjerregaard P (2012) Assessment of consumption of marine food in Greenland by a food frequency questionnaire and biomarkers. Int J Circumpolar Health 71: 18361. 18361 [pii].

45.  Joergensen C, Reinhard H, Schmedes A, Hansen PR, Wiinberg N, Petersen CL, Winther K, Parving HH, Jacobsen PK, Rossing P (2012) Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care 35: 168-172.

46.  Johansen NB, Hvidt KN, Laugesen E, Boesby L, Lundby-Christensen L, Bosselmann H, Wiinberg N (2012) Karstivhed og åreforkalkning - i teori og praksis - www.dahs.dk.

47.  Johansen NB, Charles M, Vistisen D, Rasmussen SS, Wiinberg N, Borch-Johnsen K, Lauritzen T, Sandbæk A, Witte DR (2012) Effect of intensive multifactorial treatment compared with routine care on aortic stiffness and central blood pressure among individuals with screen-detected type 2 diabetes: The ADDITION-Denmark study. Diabetes Care 35: 2207-2214.

48.  Johansen NB, Vistisen D, Brunner EJ, Tabák AG, Shipley MJ, Wilkinson IB, McEniery CM, Roden M, Herder C, Kivimäki M, Witte DR (2012) Determinants of aortic stiffness: 16-year follow-up of the Whitehall II study. PLoS ONE 7: e37165.

49.  Johansen NB, Hansen AL, Mygind JT, Philipsen A, Rasmussen SS, Jorgensen ME, Simmons RK, Lauritzen T, Sandbaek A, Witte DR (2012) Protocol for ADDITION-PRO: a longitudinal cohort study of the cardiovascular experience of individuals at high risk for diabetes recruited from Danish primary care. BMC Public Health 12: 1078.

50.  Johnson JA, Carstensen B, Witte D, Bowker SL, Lipscombe L, Renehan AG (2012) Diabetes and cancer (1): Evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia 55: 1607-1618.

51.  Jorgensen ME, Borch-Johnsen K, Witte DR, Bjerregaard P (2012) Diabetes in Greenland and its relationship with urbanization. Diabet Med 29: 755-760.

52.  Juelskjær M, Schwennesen N (2012) Intra-actice entanglements: An interview with with Karen Barad. Kvinder, køn og forskning 1-2: 10-23.

53.  Jørgensen ME, Borch-Johnsen K, Witte DR, Bjerregaard P (2012) Diabetes in Greenland and its relationship with urbanization. Diabetic Medicine 29: 755-760.

54.  Jørgensen R, Hansson L, Zoffmann V (2012) Changes in persistent delusions in schizophrenia using guided self-determination: A single case study. Issues in Mental Health Nursing 33: 293-300.

55.  Kofod-Andersen K, Tarnow L (2012) Prevalence of gastroparesis-related symptoms in an unselected cohort of patients with Type 1 diabetes. Journal of Diabetes and its Complications 26: 89-93.

56.  Konradsen H, Kirkevold M, McCallin A, Cayé-Thomasen P, Zoffmann V (2012) Breaking the silence: Integration of facial disfigurement after surgical treatment for cancer. Qualitative Health Research 22: 1037-1046.

57.  Krarup NT, Grarup N, Banasik K, Friedrichsen M, Færch K, Sandholt CH, Jørgensen T, Poulsen P, Witte DR, Vaag A, Sørensen T, Pedersen O, Hansen T (2012) The PNPLA3 rs738409 G-Allele associates with reduced fasting serum triglyceride and serum cholesterol in danes with impaired glucose regulation. PLoS ONE 7: e40376.

58.  Kristensen PL, Pedersen-Bjergaard U, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Parving HH, Thorsteinsson B, Tarnow L (2012) A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design. BMC Endocrine Disorders 12.

59.  Kristensen PL, Hansen LS, Jespersen MJ, Pedersen-Bjergaard U, Beck-Nielsen H, Christiansen JS, Nørgaard K, Perrild H, Parving HH, Thorsteinsson B, Tarnow L (2012) Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Research and Clinical Practice 96: 17-23.

60.  Lux A, Ostri C, Dyrberg E, Sander B, Lund-Andersen H, La Cour M (2012) Survival rates after diabetic vitrectomy compared with standard diabetes and general populations. Acta Ophthalmologica 90: e650-e652.

61.  Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang L, Coresh J, De Jong PE, Astor BC (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: A meta-analysis. The Lancet 380: 1649-1661.

62.  Mischak H, Ioannidis JP, Argiles A, Attwood TK, Bongcam-Rudloff E, Broenstrup M, Charonis A, Chrousos GP, Delles C, Dominiczak A, Dylag T, Ehrich J, Egido J, Findeisen P, Jankowski J, Johnson RW, Julien BA, Lankisch T, Leung HY, Maahs D, Magni F, Manns MP, Manolis E, Mayer G, Navis G, Novak J, Ortiz A, Persson F, Peter K, Riese HH, Rossing P, Sattar N, Spasovski G, Thongboonkerd V, Vanholder R, Schanstra JP, Vlahou A (2012) Implementation of proteomic biomarkers: Making it work. European Journal of Clinical Investigation 42: 1027-1036.

63.  Mogensen UM, Jensen T, Køber L, Kelbæk H, Mathiesen AS, Dixen U, Rossing P, Hilsted J, Kofoed KF (2012) Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes 61: 1822-1830.

64.  Mubyazi GM, Bloch P, Byskov J, Magnussen P, Bygbjerg IC, Hansen KS (2012) Supply-related drivers of staff motivation for providing intermittent preventive treatment of malaria during pregnancy in Tanzania: evidence from two rural districts. Malar J 11: 48.

65.  Munch IC, Kessel L, Borch-Johnsen K, Glümer C, Lund-Andersen H, Larsen M (2012) Microvascular retinopathy in subjects without diabetes: The Inter99 Eye Study. Acta Ophthalmologica 90: 613-619.

66.  Nielsen SE, Persson F, Frandsen E, Sugaya T, Hess G, Zdunek D, Shjoedt KJ, Parving HH, Rossing P (2012) Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: A randomized placebo-controlled crossover study. Diabetic Medicine 29: e184-e190.

67.  Nielsen SE, Reinhard H, Zdunek D, Hess G, Gutiérrez OM, Wolf M, Parving HH, Jacobsen PK, Rossing P (2012) Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. Diabetes Research and Clinical Practice 97: 71-76.

68.  Nielsen SE, Rossing K, Hess G, Zdunek D, Jensen BR, Parving HH, Rossing P (2012) The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP. Scandinavian Journal of Clinical and Laboratory Investigation 72: 137-142.

69.  Nielsen SE, Rossing P (2012) The authors reply. Kidney International 81: 707.

70.  Nielsen SS, Hempler NF, Waldorff FB, Kreiner S, Krasnik A (2012) Is there equity in use of healthcare services among immigrants, their descendents, and ethnic Danes? Scandinavian Journal of Public Health 40: 260-270.

71.  Nin JWM, Ferreira I, Schalkwijk CG, Jorsal A, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CDA (2012) Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12 year follow-up study. Diabetologia 55: 2489-2493.

72.  Nnko SE, Whyte SR, Geissler WP, Aagaard-Hansen J (2012) Scepticism towards insecticide treated mosquito nets for malaria control in rural community in north-western Tanzania. Tanzania Journal of Health Research 14: 1-11.

73.  Nolan JJ, Færch K (2012) Estimating insulin sensitivity and beta cell function: Perspectives from the modern pandemics of obesity and type 2 diabetes. Diabetologia 55: 2863-2867.

74.  Novotny GW, Belling KC, Bramsen JB, Nielsen JE, Bork-Jensen J, Almstrup K, Sonne SB, Kjems J, Rajpert-De Meyts E, Leffers H (2012) MicroRNA expression profiling of carcinoma in situ cells of the testis. Endocrine-Related Cancer 19: 365-379.

75.  Parving HH, Brenner BM, McMurray JJV, De Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. New England Journal of Medicine 367: 2204-2213.

76.  Parving HH, Brenner BM, McMurray JJV, De Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Nicolaides M, Richard A, Xiang Z, Armbrecht J, Pfeffer MA (2012) Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE). JRAAS - Journal of the Renin-Angiotensin-Aldosterone System 13: 387-393.

77.  Pedersen M, Pedersen KK, Bruunsgaard H, Krabbe KS, Thomsen C, Færch K, Pedersen BK, Mortensen EL (2012) Cognitive Functions in Middle Aged Individuals Are Related to Metabolic Disturbances and Aerobic Capacity: A Cross-Sectional Study. PLoS ONE 7: e51132.

78.  Persson F, Rossing P (2012) Nyresygdom ved type 2-diabetes. Ugeskrift for Laeger 174: 2150-2154.

79.  Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Parving HH (2012) Impact of glycaemic control on the effect of direct renin inhibition in the AVOID study. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System 13: 250-253.

80.  Persson F, Rathcke CN, Gall MA, Parving HH, Vestergaard H, Rossing P (2012) High YKL-40 levels predict mortality in patients with type 2 diabetes. Diabetes Research and Clinical Practice 96: 84-89.

81.  Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Hans-Henrik P (2012) Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: An AVOID substudy. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System 13: 118-121.

82.  Peyrot M, Burns KK, Davies M, Forbes A, Hermanns N et al. (2012) Diabetes Attitudes Wishes and Needs 2 (DAWN2): A multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Research and Clinical Practice. In press.

83.  Poulsen HE, Specht E, Broedbaek K, Henriksen T, Ellervik C, Mandrup-Poulsen T, Tonnesen M, Nielsen PE, Andersen HU, Weimann A (2012) RNA modifications by oxidation: A novel disease mechanism? Free Radical Biology and Medicine 52: 1353-1361.

84.  Rabbani N, Adaikalakoteswari A, Rossing K, Rossing P, Tarnow L, Parving HH, Thornalley PJ (2012) Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria. Amino Acids 42: 1627-1639.

85.  Reinhard H, Garde E, Skimminge A, Åkeson P, Ramsøy TZ, Winther K, Parving HH, Rossing P, Jacobsen PK (2012) Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients. Cardiovascular Diabetology 11.

86.  Reinhard H, Hansen PR, Wiinberg N, Kjær A, Petersen CL, Winther K, Parving HH, Rossing P, Jacobsen PK (2012) NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients. Cardiovascular Diabetology 11.

87.  Ribel-Madsen R, Fraga MF, Jacobsen S, Bork-Jensen J, Lara E, Calvanese V, Fernandez AF, Friedrichsen M, Vind BF, Højlund K, Beck-Nielsen H, Esteller M, Vaag A, Poulsen P (2012) Genome-Wide Analysis of DNA Methylation Differences in Muscle and Fat from Monozygotic Twins Discordant for Type 2 Diabetes. PLoS ONE 7: e51302.

88.  Rogvi S, Tapager I, Almdal TP, Schiotz ML, Willaing I (2012) Patient factors and glycaemic control--associations and explanatory power. Diabet Med 29: e382-e389.

89.  Rossing P, Adolphsen H, Ravnkilde SS, Cerqueira C, Friborg S (2012) Kvalitetssikring i behandling af en folkesygdom: Diabetes. Ugeskrift for Laeger 174: 2551.

90.  Rossing P (2012) Assessment of kidney function: UACR-two risk markers or a 24 h collection in a minute? Nature Reviews Nephrology 8: 320-321.

91.  Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T, McKay GJ, Williams WW, Sadlier DM, Mäkinen VP, Swan EJ, Palmer C, Boright AP, Ahlqvist E, Deshmukh HA, Keller BJ, Huang H, Ahola AJ, Fagerholm E, Gordin D, Harjutsalo V, He B, Heikkilä O, Hietala K, Kytö J, Lahermo P, Lehto M, Lithovius R, Osterholm AM, Parkkonen M, Pitkäniemi J, Rosengård-Bärlund M, Saraheimo M, Sarti C, Söderlund J, Soro-Paavonen A, Syreeni A, Thorn LM, Tikkanen H, Tolonen N, Tryggvason K, Tuomilehto J, Wadén J, Gill GV, Prior S, Guiducci C, Mirel DB, Taylor A, Hosseini SM, Parving HH, Rossing P, Tarnow L, Ladenvall C, Alhenc-Gelas F, Lefebvre P, Rigalleau V, Roussel R, Tregouet DA, Maestroni A, Maestroni S, Falhammar H, Gu T, Möllsten A, Cimponeriu D, Ioana M, Mota M, Mota E, Serafinceanu C, Stavarachi M, Hanson RL, Nelson RG, Kretzler M, Colhoun HM, Panduru NM, Gu HF, Brismar K, Zerbini G, Hadjadj S, Marre M, Groop L, Lajer M, Bull SB, Waggott D, Paterson AD, Savage DA, Bain SC, Martin F, Hirschhorn JN, Godson C, Florez JC, Groop PH, Maxwell AP, Böger CA (2012) New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes. PLoS Genetics 8: e1002921.

92.  Schiøtz M, Frølich A, Krasnik A, Taylor W, Hsu J (2012) Social organization of self-management support of persons with diabetes: A health systems comparison. Scandinavian Journal of Primary Health Care 30: 189-194.

93.  Schiøtz M, Strandberg-Larsen M, Frølich A, Krasnik A, Bellows J, Kristensen JK, Vedsted P, Eskildsen P, Beck-Nielsen H, Hsu J (2012) Self-Management Support to People with Type 2 Diabetes - A comparative study of Kaiser Permanente and the Danish Healthcare System. BMC Health Services Research 12.

94.  Schiøtz M, Bøgelund M, Almdal T, Willaing I (2012) Discrete choice as a method for exploring education preferences in a Danish population of patients with type 2 diabetes. Patient Education and Counselling 87: 217-225.

95.  Schiøtz M, Bøgelund M, Willaing I (2012) Challenges using online surveys in a Danish population of people with type 2 diabetes. Chronic Illness 8: 56-63.

96.  Schiøtz ML, Bøgelund M, Almdal T, Jensen BB, Willaing I (2012) Social support and self-management behaviour among patients with Type 2 diabetes. Diabetic Medicine 29: 654-661.

97.  Schwennesen N, Koch L (2012) Representing and intervening: 'doing' good care in first trimester prenatal knowledge production and decision-making. Sociol Health Illn 34: 283-298.

98.  Schwennesen N (2012) At the margins of life: Making fetal life matter in trajectories of first trimester prenatal risk assessment (FTPRA). In: Vermeulen N, Tamminen S, Webster A, editors. Bio-Objects: Life in the 21st Century. Ashgate. pp. 117-131.

99.  Scott RA, Chu AY, Grarup N, Manning AK, Hivert MF, Shungin D, Tönjes A, Yesupriya A, Barnes D, Bouatia-Naji N, Glazer NL, Jackson AU, Kutalik Z, Lagou V, Marek D, Rasmussen-Torvik LJ, Stringham HM, Tanaka T, Aadahl M, Arking DE, Bergmann S, Boerwinkle E, Bonnycastle LL, Bornstein SR, Brunner E, Bumpstead SJ, Brage S, Carlson OD, Chen H, Chen YDI, Chines PS, Collins FS, Couper DJ, Dennison EM, Dowling NF, Egan JS, Ekelund U, Erdos MR, Forouhi NG, Fox CS, Goodarzi MO, Grässler J, Gustafsson S, Hallmans G, Hansen T, Hingorani A, Holloway JW, Hu FB, Isomaa B, Jameson KA, Johansson I, Jonsson A, Jørgensen T, Kivimaki M, Kovacs P, Kumari M, Kuusisto J, Laakso M, Lecoeur C, Lévy-Marchal C, Li G, Loos RJF, Lyssenko V, Marmot M, Marques-Vidal P, Morken MA, Müller G, North KE, Pankow JS, Payne F, Prokopenko I, Psaty BM, Renström F, Rice K, Rotter JI, Rybin D, Sandholt CH, Sayer AA, Shrader P, Schwarz PEH, Siscovick DS, Stancáková A, Stumvoll M, Teslovich TM, Waeber G, Williams GH, Witte DR, Wood AR, Xie W, Boehnke M, Cooper C, Ferrucci L, Froguel P, Groop L, Kao WHL, Vollenweider P, Walker M, Watanabe RM, Pedersen O, Meigs JB, Ingelsson E, Barroso I, Florez JC, Franks PW, Dupuis J, Wareham NJ, Langenberg C (2012) No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes 61: 1291-1296.

100.  Secher AL, Madsen AB, Ringholm L, Barfred C, Stage E, Andersen HU, Damm P, Mathiesen ER (2012) Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. Diabetic Medicine 29: 272-277.

101.  Snoek FJ, Kersch NYA, Eldrup E, Harman-Boehm I, Hermanns N, Kokoszka A, Matthews DR, Mcguire BE, Pibernik-Okanovi´c M, Singer J, De Wit M, Skovlund SE (2012) Monitoring of individual needs in diabetes (MIND)-2: Follow-up data from the cross-national diabetes attitudes, wishes, and needs (DAWN) MIND study. Diabetes Care 35: 2128-2132.

102.  Soulimane S, Simon D, Shaw J, Witte D, Zimmet P, Vol S, Borch-Johnsen K, Magliano D, Vistisen D, Balkau B (2012) HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R. Diabetes Research and Clinical Practice 96: 392-399.

103.  Storm I (2012) Når patientuddannelse øger ulighed i sundhed. Sygeplejersken 112: 90-93.

104.  Svensson J, Eising S, Hougaard DM, Mortensen HB, Skogstrand K, Simonsen LB, Carstensen B, Nilsson A, Lernmark Å, Pociot F, Johannesen J (2012) Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings. Human Immunology 73: 1116-1126.

105.  Svensson J, Eising S, Mortensen HB, Christiansen M, Laursen I, Lernmark T, Nilsson A, Simonsen LB, Carstensen B, Pociot F, Johannesen J (2012) High levels of immunoglobulin E and a continuous increase in immunoglobulin G and immunoglobulin M by age in children with newly diagnosed type 1 diabetes. Human Immunology 73: 17-25.

106.  Tabàk AG, Carstensen M, Witte DR, Brunner EJ, Shipley MJ, Jokela M, Roden M, Kivimaki M, Herder C (2012) Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study. Diabetes Care 35: 2540-2547.

107.  Theilade S, Lajer M, Joergensen C, Persson F, Rossing P (2012) Discrepancy Between Tonometric Ambulatory and Cuff-Based Office Blood Pressure Measurements in Patients With Type 1 Diabetes. Journal of Clinical Hypertension 14: 686-693.

108.  Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P (2012) Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes. Diabetic Medicine 29: 990-994.

109.  Theilade S, Joergensen C, Persson F, Lajer M, Rossing P (2012) Ambulatory tonometric blood pressure measurements in patients with diabetes. Diabetes Technology and Therapeutics 14: 453-456.

110.  Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P (2012) Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy. Diabetic Medicine 29: 337-344.

111.  van Aerde MA, Witte DR, Jeppesen C, Soedamah-Muthu SS, Bjerregaard P, Jørgensen ME (2012) Glycemic index and glycemic load in relation to glucose intolerance among Greenland's Inuit population. Diabetes Research and Clinical Practice 97: 298-305.

112.  Vienberg SG, Brøns C, Nilsson E, Astrup A, Vaag A, Andersen B (2012) Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls. European Journal of Endocrinology 167: 49-57.

113.  Vistisen D, Lee CMY, Colagiuri S, Borch-Johnsen K, Glümer C (2012) A globally applicable screening model for detecting individuals with undiagnosed diabetes. Diabetes Research and Clinical Practice 95: 432-438.

114.  Zoffmann V, Kirkevold M (2012) Realizing empowerment in difficult diabetes care: A guided self-determination intervention. Qualitative Health Research 22: 103-118.

115.  Zürbig P, Jerums G, Hovind P, MacIsaac RJ, Mischak H, Nielsen SE, Panagiotopoulos S, Persson F, Rossing P (2012) Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes 61: 3304-3313.


PhD thesis
Juni 2012, Charlotte Jeppesen, Cand.Scient: Traditional food in Greenland: Relation to dietary recommendations, biomarkers and glucose intolerance. Syddansk Universitet.

Juli 2012, Brynjulf Mortensen, Cand.Scient: The impact of the intrauteine environment, exercise and physical inactivity on the skeletal muscle AMPK system and downstream targets. Københavns Universitet.

December 2012, Christel Asserina Bjerregaard Jørgensen, Læge: The role of vitamin D in diabetic complications – prognostic impact and therapeutic potential. Københavns Universitet.
.

Master's degree
Juni 2012, Gry Søbye: Måling af fysisk aktivitet. En metode sammenligning af ActivPal og Actiheart. Forsvar af Projekt II. Københavns Universitet.

Marts 2012, Annemarie Varming: Development and usability of a participatory adherence programme aimed at patients with type 2 diabetes in poor glycemic control. Københavns Universitet.

Sidst opdateret 06-12-2016